SynthesisAnnals of hematology2021

Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis.

Leonardo Javier Arcuri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.